Africa steps up battle against mpox outbreaks

Jon Cohen

DOI: https://doi.org/10.1126/science.adq0315

IF: 56.9

2024-04-27

Science

Abstract:Research consortium announced as new variant spreads in Congolese mining region

multidisciplinary sciences

What problem does this paper attempt to address?

Democratic Republic of the Congo: a strengthened response to mpox could help revitalise the country's healthcare system

Faraan Rahim,Cameron Sabet,Serge Holenn,Julian Hertz

DOI: https://doi.org/10.1136/bmj.q1004

2024-05-03

BMJ

Abstract:Since 1 January 2023, the Democratic Republic of the Congo (DRC) has reported over 13 000 suspected cases of mpox and more than 600 deaths, marking the region's largest recorded outbreak.1 Cases have been documented across 22 of DRC's 26 provinces, including major outbreaks in urban areas like Kinshasa and Goma.1 Although the clade I mpox virus has been endemic to central regions of DRC since the 1970s, a new, mutated strain of the virus known as clade Ib was reported in Kamituga in April 2024 and has alarmed global experts with its enhanced transmissibility and ability to evade detection by some tests.2 Researchers attribute the recent rise in mpox cases and spread of the new clade Ib virus to sexual transmission among key populations such as men who have sex with men.3Against this backdrop, DRC's public health response to the mpox epidemic over the past year has faced substantial...

medicine, general & internal
Sustained Human Outbreak of a New MPXV Clade I Lineage in the Eastern Democratic Republic of the Congo

Emmanuel Hasivirwe Vakaniaki,Cris Kacita,Eddy Kinganda-Lusamaki,Áine O’Toole,Tony Wawina-Bokalanga,Daniel Mukadi-Bamuleka,Adrienne Amuri-Aziza,Nadine Malyamungu-Bubala,Franklin Mweshi-Kumbana,Léandre Mutimbwa-Mambo,Freddy Belesi-Siangoli,Yves Mujula,Edyth Parker,Pauline-Chloé Muswamba-Kayembe,Sabin S. Nundu,Robert S. Lushima,Jean-Claude Makangara-Cigolo,Noella Mulopo-Mukanya,Elisabeth Pukuta-Simbu,Prince Akil-Bandali,Hugo Kavunga,Ombotimbe Abdramane,Isabel Brosius,Eugene Bangwen,Koen Vercauteren,Nadia A. Sam-Agudu,Edward J. Mills,Olivier Tshiani-Mbaya,Nicole A. Hoff,Anne W. Rimoin,Lisa E. Hensley,Jason Kindrachuk,Cheryl Baxter,Tulio de Oliveira,Ahidjo Ayouba,Martine Peeters,Eric Delaporte,Steve Ahuka-Mundeke,Emma L. Mohr,Nancy J. Sullivan,Jean-Jacques Muyembe-Tamfum,Jean B. Nachega,Andrew Rambaut,Laurens Liesenborghs,Placide Mbala-Kingebeni

DOI: https://doi.org/10.1038/s41591-024-03130-3

IF: 82.9

2024-06-14

Nature Medicine

Abstract:Outbreaks of mpox have historically resulted from zoonotic spillover of clade I monkeypox virus (MPXV) in Central Africa and clade II MPXV in West Africa. In 2022, subclade IIb caused a global epidemic linked to transmission through sexual contact. Here, we describe the epidemiological and genomic features of an mpox outbreak in a mining region in the Eastern Democratic Republic of the Congo (DRC), caused by clade I MPXV. Surveillance data collected between September 2023 and January 2024 identified 241 suspected cases. Genomic analysis demonstrates a distinct clade I lineage divergent from previously circulating strains in the DRC. Of the 108 PCR-confirmed mpox cases, the median age of individuals was 22 years, 51.9% were female, and 29% were sex workers, suggesting a potential role for sexual transmission. The predominance of APOBEC3-type mutations and the estimated emergence time around mid-September 2023 imply recent sustained human-to-human transmission.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Africa aims to avert an mpox pandemic

Nicaise Ndembi,Salim S. Abdool Karim

DOI: https://doi.org/10.1126/science.adt4793

IF: 56.9

2024-10-05

Science

Abstract:Last month, when the world's most populus country, India, reported its first case of the new, highly transmissible clade Ib mpox variant, the challenge of containing the virus was once again evident. Only a few weeks before that in August, the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) declared mpox a public health emergency in response to its spread in Africa. Since then, cases of clade Ib mpox have been reported in Sweden, Thailand, and Pakistan. Although mpox is not yet a global pandemic, the new variant may tip the scales in that direction if the world does not act quickly to mitigate its spread in Africa.

multidisciplinary sciences
Clade I Monkeypox virus genomic diversity in the Democratic Republic of the Congo, 2018 - 2024: Predominance of Zoonotic Transmission

Eddy Kinganda Lusamaki,Adrienne Amuri Aziza,Nicolas Fernandez Nunez,Jean-Claude Makangara-Cigolo,Catherine B. Pratt,Emmanuel Hasivirwe Vakaniaki,Nicole A. Hoff,Gradi Luakanda - Ndelemo,Prince Akil-Bandali,Sabin Sabiti Nundu,Noella Mulopo-Mukanya,Michel Ngimba,Brigitte Modadra-Madakpa,Ruth Diavita,Princesse Paku,Elisabeth Pukuta-Simbu,Sydney Merritt,Aine O'Toole,Nicola Low,Antoine Nkuba-Ndaye,Hugo Kavunga-Membo,Robert Shongo,Laurens Liesenborghs,Tony Wawina-Bokalanga,Koen Vercauteren,Daniel Mukadi-Bamuleka,Lorenzo Subissi,Jean-Jacques Tamfum Muyembe,Jason Kindrachuk,Ahidjo Ayouba,Andrew Rambaut,Eric Delaporte,Sofonias K. Tessema,Eric D'Ortenzio,Anne W. Rimoin,Lisa E. Hensley,Placide Mbala-Kingebeni,Martine Peeters,Steve Ahuka-Mundeke

DOI: https://doi.org/10.1101/2024.08.13.24311951

2024-08-22

Abstract:Background: Recent reports raise concerns on the changing epidemiology of mpox in the Democratic Republic of the Congo (DRC), with increasing case counts, sexual contact-mediated clusters, and sustained human-to-human transmission driven by a novel monkeypox virus (MPXV) subclade, clade Ib. However, only a limited number of clade I MPXV genomes have been characterized so far, from a limited number of regions. Methods: We conducted whole genome sequencing of 603 mpox-positive samples that were collected from 581 patients between 2018-2024 in 17 of the 26 provinces of the DRC. Results: Genome coverage was at least 70% for 429/603 (71.1%) samples and near full-length MPXV genomes (>90% coverage) were obtained for 348/603 (57.7%) samples from 337 patients. All newly generated MPXV sequences belonged to clade I, among which 17 were clade Ib strains, all from patients infected in 2024 in the South-Kivu province. The large majority (>95%) of the new strains fall within previously described clade Ia groups and potential new groups have also been observed. The low number of APOBEC3 mutations found among clade Ia suggests that most human mpox cases are probably linked to zoonotic transmissions. Genetically diverse MPXV lineages co-circulate in small geographic areas during the same outbreak suggesting multiple zoonotic introductions over a short period from one or multiple reservoir species. Recent identification of mpox cases in Kinshasa shows that multiple lineages circulate in a large urban center, indicating separate introduction events. Conclusion: The mpox epidemic in the DRC exhibits two distinct patterns. In traditional endemic regions, the epidemic is predominated by zoonotic spill-over events involving clade Ia. Conversely, in the eastern part of the country, the clade Ib outbreak is driven by human-to-human transmission highlighting the need for a coordinated response effort at the national, regional and international levels.
Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024

Tony Wawina-Bokalanga,Prince Akil-Bandali,Eddy Kinganda-Lusamaki,Emmanuel Lokilo,Daan Jansen,Adrienne Amuri-Aziza,Jean-Claude Makangara-Cigolo,Elisabeth Pukuta-Simbu,Rilia Ola-Mpumbe,Mamito Muyembe,Cris Kacita,Princesse Paku-Tshambu,Pedro HLF Dantas,Olivier Tshiani-Mbaya,Gradi Luakanda,Antoine Nkuba-Ndaye,Meris Matondo,Emmanuel Hasivirwe Vakaniaki,Sofonias Tessema,Nicaise Ndembi,Áine O'Toole,Tessa De Block,Christian Ngandu,Nicole A Hoff,Nicola Low,Lorenzo Subissi,Sydney Merritt,Jean-Jacques Muyembe-Tamfum,Laurens Liesenborghs,Martine Peeters,Eric Delaporte,Jason Kindrachuk,Anne W Rimoin,Steve Ahuka-Mundeke,Andrew Rambaut,Dieudonné Mwamba,Koen Vercauteren and Placide Mbala-Kingebeni

DOI: https://doi.org/10.2807/1560-7917.es.2024.29.38.2400592

2024-09-21

Eurosurveillance

Abstract:Between January and August 2024, mpox cases have been reported in nearly all provinces of the Democratic Republic of the Congo (DRC). Monkeypox virus genome sequences were obtained from 11 mpox cases' samples, collected in July–August 2024 in several health zones of Kinshasa. Characterisation of the sequences showed subclades Ia and Ib co-circulating in the Limete health zone, while phylogenetic analyses suggested multiple introductions of the two subclades in Kinshasa. This illustrates the growing complexity of Clade I mpox outbreaks in DRC.

infectious diseases
Documented transboundary transmission of mpox between the Central African Republic and the Democratic Republic of the Congo

Emmanuel Hasivirwe Vakaniaki,Eddy Lusamaki,Sydney Merritt,Francois Kasongo,Emile Malembi,Lygie Lunyanga,Sylvie Linsuke,Megan Halbrook,Ernest Kalthan,Elisabeth Pukuta,Adrienne Amuri Aziza,Jean Claude Makangara,Raphael Lumembe,Gabriel Kabamba,Yvon Anta,Pierrot Bolunza,Innocent Kanda,Raoul Nganzobo,Thierry Kalonji,Justus M Nsio,Patricia Matoka,Dieudonne Mwamba,Christian Ngandu,Souradet Y Shaw,Robert Shongo,Joule Madinga,Yap Boum,Laurens Liesenborghs,Eric Delaporte,Ahidjo Ayouba,Nicola Low,Steve Ahuka Mundeke,Lisa E Hensley,Jean-Jacques Tamfum Muyembe,Emmanuel Nakoune,Martine Peeters,Nicole A Hoff,Jason Kindrachuk,Anne W Rimoin,Placide Mbala-Kingebeni

DOI: https://doi.org/10.1101/2024.08.13.24311555

2024-08-14

Abstract:Four confirmed mpox cases in South Ubangi province, Democratic Republic of the Congo, were linked to documented transboundary transmission from Central African Republic. Viral genome sequencing shows that the MPXV sequences belong to subclade Ia. This demonstrates the borderless nature of mpox and highlights the need for vigilant regional surveillance.
Co-circulation of Clade Ia and Ib monkeypox virus in Kinshasa Province, Democratic Republic of the Congo, July - August 2024

Tony Wawina-Bokalanga,Prince Akil-Bandali Sr.,Eddy Kinganda Lusamaki,Emmanuel Lokilo,Daan Jansen,Adrienne Amuri-Aziza,Jean-Claude Makangara-Cigolo,Elisabeth Pukuta-Simbu,Rilia Ola-Mpumbe,Cris Kacita,Princesse Paku-Tshambu,Pedro-Henrique L.F. Dantas,Gradi Luakanda,Antoine Nkuba-Ndaye,Meris Matondo,Junior Bulabula,Emmanuel Hasivirwe Vakaniaki,Aine O'Toole,Tessa De Block,Christian Ngandu,Nicole A Hoff,Nicola Low,Lorenzo Subissi,Sydney Merritt,Jean-Jacques Tamfum Muyembe,Laurens Liesenborghs,Martine Peeters,Eric Delaporte,Jason Kindrachuk,Anne W. Rimoin,Steve Ahuka-Mundeke,Andrew Rambaut,Dieudonne Mwamba,Koen Vercauteren,Mbala Placide

DOI: https://doi.org/10.1101/2024.09.03.24312937

2024-09-04

Abstract:Mpox cases have been reported in nearly all provinces of the Democratic Republic of the Congo as of August 2024. Monkeypox virus positive samples from Kinshasa, collected between July and mid-August 2024, were sequenced using a probe-based enrichment or optimized tiling sequencing protocol. With multiple introductions of both Clade Ia (7/12) and Ib (5/12), marking Kinshasa, and its Limete health zone specifically, as an area with co-circulation of both Clade I, a unique observation illustrating the growing complexity of Clade I mpox outbreaks in DRC.
Epidemiology and Phylogenomic Characterization of Distinct 2023 and 2024 Mpox outbreaks in Kinshasa, Democratic Republic of the Congo - Evidence for increasingly sustained human-to-human transmission of subclade Ia

Tony Wawina-Bokalanga,Sydney Merritt,Eddy Kinganda Lusamaki,Daan Jansen,Megan Halbrook,Elisabeth Pukuta-Simbu,Aine O'Toole,Emmanuel Hasivirwe Vakaniaki,Rilia Ola-Mpumbe,Papy Kwete,Prince Akil-Bandali,Cris Kacita,Ange Ponga-Museme,Nelson Mapenzi-Kashali,Adrienne Amuri-Aziza,Olivier Tshiani-Mbaya,Princesse Paku-Tshambu,Pedro HLF Dantas,Tessa de Block,Emmanuel Lokilo,Chloe Muswamba,Jean-Claude Makangara-Cigolo,Gradi Luakanda,Christian Ngandu,David J. Kelvin,Catherine Pratt,Ahidjo Ayouba,Sofonias Tessema,Nicaise Ndembi,Antonio Mauro Rezende,Eric Delaporte,Dieudonne Mwamba,Lorenzo Subissi,Laurens Liesenborghs,Nicole A Hoff,Martine Peeters,Nicola Low,Steve Ahuka-Mundeke,Jean-Jacques Tamfum Muyembe,Anne W. Rimoin,Jason Kindrachuk,Koen Vercauteren,Andrew Rambaut,Mbala Placide

DOI: https://doi.org/10.1101/2024.11.15.24317404

2024-11-16

Abstract:Background: Monkeypox virus (MPXV) is endemic to the Democratic Republic of the Congo (DRC), and historically has been reported in rural, forested regions with limited household and primarily zoonotic transmission. With the emergence of subclade Ib and increasing reported human-to-human transmission of MPXV we sought to characterize both the epidemiologic and genomic characteristics of confirmed mpox cases in Kinshasa, DRC, following confirmed MPXV introduction in August 2023. Methods: This retrospective observational study leveraged demographic and case-investigation data, as well as biological samples, collected from suspected mpox cases in Kinshasa from January 2023 to September 2024 as part of routine national surveillance. Samples were tested at the Institut National de Recherche Biomedicale first by qPCR to confirm MPXV, and subsequently sequenced for genomic analysis for those samples with a cycle threshold value <31. Findings: Epidemiological characterization of all confirmed mpox cases in Kinshasa indicated two distinct periods of MPXV introduction and circulation: first, following the initial case in August 2023, self-limiting transmission chains of subclade Ia primarily among men. Case investigations from this period suggest human human transmission. The second period is marked by the introduction of subclade Ib to the city and expanded co-circulation of both subclades with Limete health zone reporting the most cases of both subclades. Of those samples sequenced, genomic analysis indicated that greater than 60% of mutations in both subclades were consistent with APOBEC3-driven mutations. Interpretation: These data suggest that as of July 2024, MPXV in Kinshasa has undergone an epidemiological shift with sustained human-to-human transmission and co-circulation of two distinct subclades. Additionally, high rates of APOBEC3-driven changes further support this shift towards human-to-human transmission. While sexual-contact transmission cannot be confirmed without further case investigation, these data highlight important changes in mpox dynamics which may better guide mpox mitigation and containment strategies in Kinshasa.

Infectious Diseases (except HIV/AIDS)
Likely cross-border introductions of MPXV Clade I into the Republic of the Congo from the Democratic Republic of the Congo

Kwe Claude Yinda,Felix Koukouikila-Koussounda,Pembe Issamou Mayengue,Golmard Reiche Elenga,Benjamin Greene,Missiani Ochwoto,Ghislain Dzeret Indolo,Yanne Vanessa Thiecesse Mavoungou,Dachel Aymard Eyenet Boussam,Bani Reize Vishnou Ampiri,Chastel Claujens Mapanguy Mfoutou,Yvanhe Deho Kianguebeni Mbouala,Francine Ntoumi,Jean-Medard Kankou,Vincent Munster,Fabien Roch Niama

DOI: https://doi.org/10.1101/2024.08.21.24312265

2024-08-21

Abstract:Background: Mpox virus (MPXV) Clade I is endemic in several central African countries and characterized by severe disease and high mortality. Since October 2023, a large-scale Mpox outbreak has emerged in the Democratic Republic of the Congo (DRC), with 22,477 cases and 1,038 deaths reported as of May 26, 2024, and World Health organization (WHO) has declared mpox a public health emergency of international concern on august 14 2024. Twenty-three provinces in the DRC have been affected, 15 of which border another country, including the Republic of the Congo (RoC). The RoC is bordered by five of these affected provinces, increasing the risk of cross-border spread. In the RoC, Mpox cases have historically occurred in the endemic areas of the Likouala department in the north. Recently, suspected cases have emerged outside this region, and it is unclear if these cases are recent spillover events from the DRC outbreaks. Therefore, we performed molecular analyses of these cases in the RoC. Methods: Samples were collected from suspected cases between January and April 29, 2024, in Likouala, Cuvette-Centralle, and Pointe-Noire. Blood samples, skin/oropharyngeal swabs or skin crusts were obtained for molecular diagnosis at the Laboratoire National de Sante Publique (LNSP), Brazzaville. MPXV sequences were obtained and analyzed using newly established Nanopore sequencing methodology and bioinformatic pipeline. Findings: Phylogenetic analysis of sequences shows the clustering of MPXV sequences obtained from cases in RoC with sequences from the ongoing Mpox outbreak in the DRC. In addition, sequences from the RoC show multiple phylogenetic positioning suggesting the occurrence of multiple co-circulating strains in the human population. Interpretation: The close genetic relatedness between sequences from RoC and those from DRC indicates a possible cross-border transmission of MPXV from DRC to RoC. These data highlight the need for implementation of expanded surveillance in countries bordering DRC and RoC, in combination with control measures focused at containing the current outbreaks in DRC and RoC to prevent escalation into a larger-scale epidemic.

Infectious Diseases (except HIV/AIDS)
Presumed Transmission of 2 Distinct Monkeypox Virus Variants from Central African Republic to Democratic Republic of the Congo

Emmanuel Hasivirwe Vakaniaki,Eddy Kinganda-Lusamaki,Sydney Merritt,Francois Kasongo,Emile Malembi,Lygie Lunyanga,Sylvie Linsuke,Megan Halbrook,Ernest Kalthan,Elisabeth Pukuta,Adrienne Amuri Aziza,Jean Claude Makangara Cigolo,Raphael Lumembe,Gabriel Kabamba,Yvon Anta,Pierrot Bolunza,Innocent Kanda,Raoul Ngazobo,Thierry Kalonji,Justus Nsio,Patricia Matoka,Dieudonné Mwamba,Christian Ngandu,Souradet Y Shaw,Robert Shongo,Joule Madinga,Yap Boum,Laurens Liesenborghs,Eric Delaporte,Ahidjo Ayouba,Nicola Low,Steve Ahuka Mundeke,Lisa E Hensley,Jean-Jacques Muyembe Tamfum,Emmanuel Nakoune,Martine Peeters,Nicole A Hoff,Jason Kindrachuk,Anne W Rimoin,Placide Mbala-Kingebeni

DOI: https://doi.org/10.3201/eid3010.241118

2024-08-30

Abstract:We linked 4 mpox cases in South Ubangi, Democratic Republic of the Congo, to transboundary transmission from Central African Republic. Viral genome sequencing demonstrated that the monkeypox virus sequences belonged to distinct clusters of subclade Ia. This finding demonstrates the borderless nature of mpox and highlights the need for vigilant regional surveillance.
Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024

Leandre Murhula Masirika,Jean Claude Udahemuka,Leonard Schuele,Pacifique Ndishimye,Saria Otani,Justin Bengehya Mbiribindi,Jean M Marekani,Léandre Mutimbwa Mambo,Nadine Malyamungu Bubala,Marjan Boter,David F Nieuwenhuijse,Trudie Lang,Ernest Balyahamwabo Kalalizi,Jean Pierre Musabyimana,Frank M Aarestrup,Marion Koopmans,Bas B Oude Munnink,Freddy Belesi Siangoli,Jean M. Marekani,David F. Nieuwenhuijse,Frank M. Aarestrup,Bas B. Oude Munnink and Freddy Belesi Siangoli

DOI: https://doi.org/10.2807/1560-7917.es.2024.29.11.2400106

2024-03-15

Eurosurveillance

Abstract:Since the beginning of 2023, the number of people with suspected monkeypox virus (MPXV) infection have sharply increased in the Democratic Republic of the Congo (DRC). We report near-to-complete MPXV genome sequences derived from six cases from the South Kivu province. Phylogenetic analyses reveal that the MPXV affecting the cases belongs to a novel Clade I sub-lineage. The outbreak strain genome lacks the target sequence of the probe and primers of a commonly used Clade I-specific real-time PCR.

infectious diseases
Mpox continues to spread in Africa and threatens global health security

Kyeng Mercy,Bethelhem Tibebu,Mosoka Fallah,Nuno R. Faria,Nicaise Ndembi,Yenew Kebede Tebeje

DOI: https://doi.org/10.1038/s41591-024-02862-6

IF: 82.9

2024-03-14

Nature Medicine

Abstract:The African continent is a crucial part of the historical and current narrative of mpox. The first human case of mpox (then termed monkeypox) was detected in 1970 in the Democratic Republic of the Congo (DRC), long before the recent spread of the disease to other parts of the world. Although mpox has been on the African continent for over five decades, it only gained worldwide attention when it began spreading to high-income countries in Europe and North America 1 . This is reminiscent of the global neglect of Ebola virus disease in the DRC and Sudan in the mid-1970s, which only gained international attention during the 2014–2015 Ebola outbreak when cases were exported to high-income countries. As with Ebola, mpox is emblematic of the global neglect of diseases that are endemic to Africa, up until they threaten the health security of the Global North. Progress must be made to control this disease and gaps need to be addressed to achieve global health security. Before the PHEIC was declared, Africa had registered several mpox outbreaks including the 2017 outbreak in Nigeria with 122 confirmed cases and 7 deaths (case fatality rate of 5.7%) from 17 states 5 . Similarly, between 2005 and 2007, at least 760 confirmed cases of mpox were reported from the DRC. Since then, the DRC has been reporting yearly increases in mpox cases (Table 1). Despite these high numbers, there was a global neglect of mpox outbreaks until the virus began spreading in the Global North (to access a more detailed dataset, please contact AfricaCDCEBS@africa-union.org). Table 1 Confirmed cases and deaths from mpox in Africa in 2022 (1 Jan–25 Nov) and 2023 (1 Jan–25 Nov) Full size table

biochemistry & molecular biology,cell biology,medicine, research & experimental
Concurrent outbreaks of mpox in Africa—an update

Camila G Beiras,Emile Malembi,Roser Escrig-Sarreta,Steve Ahuka,Placide Mbala,Hypolite M Mavoko,Lorenzo Subissi,Ana B Abecasis,Michael Marks,Oriol Mitjà

DOI: https://doi.org/10.1016/s0140-6736(24)02353-5

IF: 202.731

2024-12-13

The Lancet

Abstract:Summary In this Review, we examine the concurrent outbreaks of mpox in Africa, focusing on clade 1a, the newly emerged clade 1b, and clade 2b lineage A, and how they differ from the 2022 global outbreak caused by clade 2b lineage B.1. Historically, clades 1a and 2a have caused sporadic, small outbreaks in central and west Africa, respectively, primarily through zoonotic transmission. Clade 2b first caused an outbreak in Nigeria in 2017, and later spread globally via sexual contact in 2022. In August, 2024, WHO declared a global health emergency due to the newly identified clade 1b outbreak in eastern Democratic Republic of the Congo. This outbreak has now expanded to several other countries and is spreading through direct and sexual contact in urban centres and refugee camps. Clades, route of exposure, infectious dose, and host immune response are the main factors influencing clinical presentation of mpox. For clades 1a and 2a, zoonotic transmission plays an important role, whereas for clades 1b and 2b, the spread occurs through sustained human-to-human transmission without zoonotic exposure. For both clades 1a and 2a, lesions have a generalised centrifugal distribution, whereas for clade 2b they are mainly localised to the anogenital area. For clade 1b, data are still emerging, but current cases show a mix of localised lesions and centrifugal distribution. The severity of the disease is higher for clade 1a (case fatality rate up to 12%) compared with other clades (case fatality rates 0–3·6%). Diagnostic challenges include false negative results for clade 1b with existing PCR assays and poor testing access in remote areas. Tecovirimat, the primary antiviral during the 2022 outbreak, has shown reduced effectiveness against clade 1a in preliminary study results, whereas its efficacy against other clades is still under investigation. The modified vaccinia Ankara–Bavarian Nordic vaccine has been shown to be up to 90% effective against clade 2b after two doses and is safe for children, although its effectiveness drops to 20% when used as post-exposure prophylaxis. Given the evolving nature of the monkeypox virus, ongoing research and strong public health responses are key to managing potential future outbreaks.

medicine, general & internal
Rapid regional mobile laboratory response and genomic monkeypox virus (MPXV) surveillance in seven East African Community partner states, August 2024: preparedness activities for the ongoing outbreak

Florian Gehre,Eric Nzeyimana,Hakim Idris Lagu,Emmanuel Achol,Julien A Nguinkal,Eric Kezakarayagwa,Théogene Ihorimbere,Néhémie Nzoyikorera,Francine Kabatesi,Marie-Noelle Uwineza,Abdi Roba,Millicent Nyakio Ndia,John Ndemi Kiiru,Gwokpan Awin Nykwec,Isaac Gatkuoth Chot Moun,Mamdouh A Aguer,James A Maror,Gregory Wani Dumo,Michael Losuba,Lul Lojok Deng,Neema Omari,Grace Ochido,Aryse Martins Melo,Peter Bernard Mtesigwa Mkama,Edna Mgimba,Monica Fredrick Francis,Lawrence A Mapunda,Alex Magesa,Nyambura Moremi,Godfrey Pimundu,Tonny Muyigi,Susan Ndidde Nabadda,Emmanuel Kabalisa,Isabelle Mukagatare,Daniel Mukadi-Bamuleka,Erick Ntambwe Kamangu,Jürgen May,Muna Affara

DOI: https://doi.org/10.2807/1560-7917.ES.2024.29.35.2400541

Abstract:The East African Community (EAC) is experiencing an unprecedented, emerging mpox outbreak since July 2024 in five of eight partner states. We highlight rapid regional response measures, initiated August 2024 coordinated by EAC: field deployment of six mobile laboratories in Burundi, Rwanda, Uganda, Tanzania, Kenya, South Sudan to high-risk areas, donation of one mobile laboratory to Democratic Republic of the Congo and genomic monkeypox virus (MPXV) surveillance support. These interventions aim to limit local mpox spread and support international containment.
First mpox vaccines arrive in Africa as officials work "blindly" to contain outbreaks

Like Taylor

DOI: https://doi.org/10.1136/bmj.q1897

2024-09-01

BMJ

Abstract:Nigeria became the first country in Africa to receive mpox vaccines on 27 August with the arrival of 10 000 doses intended to help contain the viral disease which is rapidly spreading across the continent.These and the shipments that are expected to follow should help contain mpox, although experts say there are not enough vaccines in the pipeline and that their efficacy, particularly against emerging variants, is unknown.Health officials are also unsure which areas to target first with the scarce supplies, given that the outbreaks are complex, rapidly evolving, and there are insufficient resources to monitor them, Dimie Ogoina, professor for infectious diseases at the Niger Delta University in Nigeria told journalists."We are working blindly. For instance, in the Democratic Republic of Congo (DRC), less than 40% of cases are tested and laboratory confirmed," said Ogoina, who is a member of the World Health Organization international health regulations emergency committee...

medicine, general & internal
Genetic sequencing analysis of monkeypox virus clade I in Republic of the Congo: a cross-sectional, descriptive study

Claude Kwe Yinda,Félix Koukouikila-Koussounda,Pembe Issamou Mayengue,Reiche Golmard Elenga,Benjamin Greene,Missiani Ochwoto,Ghislain Dzeret Indolo,Yanne Vanessa Thiécesse Mavoungou,Dachel Aymard Eyenet Boussam,Bani Reize Vishnou Ampiri,Chastel Claujens Mapanguy Mfoutou,Yvanhe Deho Kianguebeni Mbouala,Francine Ntoumi,Jean-Médard Kankou,Vincent J Munster,Fabien Roch Niama

DOI: https://doi.org/10.1016/S0140-6736(24)02188-3

2024-10-16

Abstract:Background: Monkeypox virus clade I is endemic in several central African countries and characterised by an increase in disease severity and mortality. Since October, 2023, a large-scale mpox outbreak has emerged in DR Congo, and in March, 2024, the first individuals with mpox were reported outside the endemic areas in Republic of the Congo. We aimed to provide insight into the epidemic by sequencing samples obtained from individuals with mpox in Republic of the Congo. Methods: In this cross-sectional, descriptive study, samples were collected from individuals with suspected mpox between Jan 15 and April 8, 2024, in Brazzaville, Pointe-Noire, Likouala, Cuvette-Centrale, and Plateaux (Republic of the Congo). Blood samples, skin or oropharyngeal swabs, or skin crusts were obtained for molecular diagnosis via real-time PCR. Monkeypox virus sequences were obtained and analysed using newly established nanopore sequencing methodology and bioinformatic pipeline. The sequences obtained were aligned and used to construct a maximum likelihood phylogenetic tree using IG-TREE. Findings: 61 samples were collected from individuals with suspected mpox, 31 of which were positive for monkeypox virus and were included in our analysis (four positive samples were excluded due to unavailability of epidemiological data or insufficient biological material). Individuals who tested positive for monkeypox virus were from Cuvette-Centrale (19 [61%] of 31), Likouala (eight [26%]), and Pointe-Noire (four [13%]). 20 (65%) were male and 11 (35%) were female. Phylogenetic analysis of sequences showed two major clusters within clade Ia. One cluster was made up of four sequences from this study clustering with two monkeypox virus sequences from the current DR Congo outbreak, three older sequences from Central African Republic sequenced between 2017 and 2018, and seven sequences from DR Congo sequenced in 2006-07 and 2022. The second cluster was made up of 16 sequences from this study clustering with sequences from the current DR Congo outbreak. In addition, sequences from Republic of the Congo show multiple phylogenetic positioning suggesting the occurrence of multiple co-circulating strains in the human population. Interpretation: Our findings suggest that multiple monkeypox virus strains are co-circulating in the human population, highlighting the need for implementation of expanded mpox surveillance, especially in countries bordering DR Congo and Republic of the Congo, in combination with control measures focused on containing the current outbreaks in these countries to prevent escalation into a larger-scale epidemic. Funding: Intramural Research Program of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses

Pierre Gashema,Tumusime Musafiri,Felix Ndahimana,Hyppolyte Iradukunda,Eric Saramba,Stuart T. Nyakatswau,Noel Gahamanyi,Patrick Gad Iradukunda,Ayman Ahmed,Tafadzwa Dzinamarira,Claude Mambo Muvunyi

DOI: https://doi.org/10.3390/v16101578

2024-10-08

Viruses

Abstract:The Africa Centers for Disease Control and Prevention declared mpox a Public Health Emergency of Continental Security (PHECS) in Africa. African public health systems have moved to mobilize a response against a backdrop of inherent significant challenges. With this commentary, we discuss how lessons from past public health emergencies, particularly COVID-19 and Ebola outbreaks, have prepared the region for improved disease surveillance, rapid response strategies, and effective public health communication and how these lessons can be applied to the mpox response, emphasizing the importance of strong healthcare infrastructure, effective data sharing, community engagement, targeted interventions, and robust contact tracing. Additionally, addressing misinformation and building public trust are crucial for controlling the spread of any disease. By leveraging these strategies, African countries can enhance their response to mpox. This includes improving diagnostic capabilities, strengthening cross-border collaborations, and prioritizing vaccination campaigns where needed. Ultimately, by applying the hard-earned lessons from the COVID-19 pandemic and Ebola outbreak, the East Africa region can better address the challenges posed by mpox and safeguard public health.

virology
Mpox is accelerating antimicrobial resistance in Africa, officials warn

Gilbert Nakweya

DOI: https://doi.org/10.1136/bmj.q2124

2024-09-28

BMJ

Abstract:The head of the Africa Centres for Disease Control and Prevention (Africa CDC) has warned that the spread of mpox is accelerating antimicrobial resistance in the continent. "Today, I consider mpox as the major driver of antimicrobial resistance," said the agency's director general, Jean Kaseya.Kaseya was speaking in New York at a symposium organised by One Health Trust, a public health research organisation, ahead of the UN high level meeting on antimicrobial resistance (AMR) on 26 September. He said that mpox was driving the use of antibiotics without prescription in Africa as people desperately look for treatment.Latest weekly figures from Africa CDC show there were 6439 confirmed mpox cases in Africa, with 840 deaths reported, and 32 010 suspected cases.1Kaseya said, "I was in one of the countries affected [by mpox] last week. I saw a young person using antibiotics for more than 45 days every day admitted in hospital,"...

medicine, general & internal
First imported Cases of MPXV Clade Ib in Goma, Democratic Republic of the Congo: Implications for Global Surveillance and Transmission Dynamics

Daniel Mukadi-Bamuleka,Eddy Kinganda Lusamaki,Noella Mulopo-Mukanya,Adrienne Amuri-Aziza,Aine O'Toole,Brigitte Modadra-Madakpa,Guy Mutombo-Ndongala,Emmanuel Hasivirwe Vakaniaki,Sydney Merritt,Cris Kacita,Gaston Lubambo Maboko,Jean Claude Makangara,Michel Ngimba,Emmanuel Lokilo,Elisabeth Pukuta-Simbu,Gradi Luakanda-Ndelemo,Tavia Bodisa-Matamu,Zephanie Paluku-Kalimuli,Prince Akil-Bandali,Sifa Kavira,Daan Jansen,Adele Kavira-Kamaliro,Emile Muhindo-Milonde,Jeriel Mufungizi,Yves Birindwa Hamisi,Hugo Kavunga-Membo,Olivier Tshiani,Sabin S Nundu,Laurens Liesenborghs,Nicole A Hoff,Jean B Nachega,Robert Shongo,Ahidjo Ayouba,Genay Pilarowski,Alain Kakule Mangolopa,Amos K. Ebondo,Nicola Low,Souradet Y. Shaw,Sam AJ Wilkinson,Sofonias Kifle Tessema,Lorenzo Subissi,Eric Delaporte,Koen Vercauteren,Tony Wawina-Bokalanga,Anne W. Rimoin,Martine Peeters,Nicholas James Loman,Andrew Rambaut,Jean-Jacques Tamfum Muyembe,Lisa E Hensley,Jason Kindrachuk,Mbala Placide,Steve Ahuka-Mundeke

DOI: https://doi.org/10.1101/2024.09.12.24313188

2024-09-16

Abstract:The ongoing national mpox outbreak in the Democratic Republic of the Congo has resulted in more >30,000 suspected cases in the country from January 2023 to August 2024. While these historic case totals have been driven by primarily by zoonosis, the emergence of Clade Ib monkeypox virus (MPXV), which is connected to more sustained human-to-human transmission, has been associated with increasing public health impacts in eastern DRC. First identified in South Kivu province, Clade Ib MPXV has been identified in multiple non-endemic East African countries for the first time. In DRC, there have been concerns over broader Clade Ib expansion in the country that could further complicate containment and mitigation responses. Here, we report the first introductions of Clade Ib into North Kivu province, including within internal displacement camps, with suspected close contact transmission that includes non-intimate contacts and children. These findings demonstrate that mpox case investigations and community messaging campaigns should include considerations for non-sexual contact-mediated transmission of Clade Ib that includes children <15 years.
Monkeypox virus: dangerous strain gains ability to spread through sex, new data suggest

Max Kozlov

DOI: https://doi.org/10.1038/d41586-024-01167-5

IF: 64.8

2024-04-25

Nature

Abstract:A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak.

multidisciplinary sciences

Africa steps up battle against mpox outbreaks

Democratic Republic of the Congo: a strengthened response to mpox could help revitalise the country's healthcare system

Sustained Human Outbreak of a New MPXV Clade I Lineage in the Eastern Democratic Republic of the Congo

Africa aims to avert an mpox pandemic

Clade I Monkeypox virus genomic diversity in the Democratic Republic of the Congo, 2018 - 2024: Predominance of Zoonotic Transmission

Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024

Documented transboundary transmission of mpox between the Central African Republic and the Democratic Republic of the Congo

Co-circulation of Clade Ia and Ib monkeypox virus in Kinshasa Province, Democratic Republic of the Congo, July - August 2024

Epidemiology and Phylogenomic Characterization of Distinct 2023 and 2024 Mpox outbreaks in Kinshasa, Democratic Republic of the Congo - Evidence for increasingly sustained human-to-human transmission of subclade Ia

Likely cross-border introductions of MPXV Clade I into the Republic of the Congo from the Democratic Republic of the Congo

Presumed Transmission of 2 Distinct Monkeypox Virus Variants from Central African Republic to Democratic Republic of the Congo

Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024

Mpox continues to spread in Africa and threatens global health security

Concurrent outbreaks of mpox in Africa—an update

Rapid regional mobile laboratory response and genomic monkeypox virus (MPXV) surveillance in seven East African Community partner states, August 2024: preparedness activities for the ongoing outbreak

First mpox vaccines arrive in Africa as officials work "blindly" to contain outbreaks

Genetic sequencing analysis of monkeypox virus clade I in Republic of the Congo: a cross-sectional, descriptive study

Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses

Mpox is accelerating antimicrobial resistance in Africa, officials warn

First imported Cases of MPXV Clade Ib in Goma, Democratic Republic of the Congo: Implications for Global Surveillance and Transmission Dynamics

Monkeypox virus: dangerous strain gains ability to spread through sex, new data suggest